StepStone Group Portfolio holdings
StepStone Group is a private markets firm that builds customized investment portfolios, monitors them and advises investors. Its business spans primary and secondary fund investments plus co-investments, across private equity, real estate, infrastructure, real assets and private debt. Its founders, Monte Brem and Thomas Keck, had earlier made private equity investments at Pacific Corporate Group, as president and managing director respectively. StepStone went public on the Nasdaq in September 2020. The firm serves institutional investors and sponsors worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MoneyLion Inc.
ML
|
+$800K |
| 2 |
JFrog
FROG
|
+$545K |
| 3 |
NeueHealth
NEUE
|
+$306K |
| 4 |
Grove Collaborative
GROV
|
+$146K |
| 5 |
Sweetgreen
SG
|
+$93K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
USER
UserTesting, Inc.
USER
|
+$14M |
| 2 |
Forge Global Holdings
FRGE
|
+$396K |
| 3 |
Procore
PCOR
|
+$392K |
| 4 |
Vacasa, Inc. Class A Common Stock
VCSA
|
+$295K |
| 5 |
Xometry
XMTR
|
+$227K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.72% |
| 2 | Financials | 38.76% |
| 3 | Healthcare | 10.69% |
| 4 | Industrials | 6.59% |
| 5 | Communication Services | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Dun & Bradstreet
DNB
| $270M | 35.55% |
22,042,226
| – | – |
2021 Q4
4 quarters
|
|
|
USER
2
DELISTED
UserTesting, Inc.
USER
| $170M | 22.4% |
22,680,906
-2,187,565
| -9% | -$14M |
2021 Q4
4 quarters
|
|
3
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $116M | 15.25% |
10,366,855
| – | – |
2021 Q3
5 quarters
|
|
4
Rocket Lab Corp
RKLB
$44.5B
| $46.3M | 6.09% |
12,273,414
| – | – |
2021 Q3
5 quarters
|
|
|
5
DELISTED
NeueHealth
NEUE
| $27.3M | 3.59% |
525,278
+4,212
| +0.8% | +$306K |
2021 Q3
5 quarters
|
|
6
UiPath
PATH
$6.85B
| $22.7M | 2.99% |
1,786,527
| – | – |
2021 Q3
5 quarters
|
|
|
IMGO
7
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $18.8M | 2.47% |
522,987
| – | – |
2021 Q3
5 quarters
|
|
|
8
DELISTED
MoneyLion Inc.
ML
| $17.3M | 2.28% |
846,159
+32,498
| +4% | +$800K |
2021 Q3
5 quarters
|
|
9
Roblox
RBLX
$37.7B
| $13.3M | 1.76% |
469,052
| – | – |
2021 Q3
5 quarters
|
|
10
DELISTED
HilleVax
HLVX
| $11.3M | 1.49% |
676,567
| – | – |
2022 Q2
2 quarters
|
|
11
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $10.5M | 1.38% |
2,849,340
| – | – |
2021 Q3
5 quarters
|
|
12
Entrada Therapeutics
TRDA
$213M
| $10.3M | 1.35% |
761,277
| – | – |
2021 Q4
4 quarters
|
|
|
NGM
13
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $7.9M | 1.04% |
1,573,357
| – | – |
2021 Q3
5 quarters
|
|
14
DELISTED
Doma Holdings, Inc.
DOMA
| $6.7M | 0.88% |
595,179
| – | – |
2021 Q3
5 quarters
|
|
15
Phathom Pharmaceuticals
PHAT
$511M
| $4.74M | 0.62% |
422,085
| – | – |
2021 Q3
5 quarters
|
|
|
16
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $3.8M | 0.5% |
150,691
-6,329
| -4% | -$295K |
2021 Q4
4 quarters
|
|
17
Tenaya Therapeutics
TNYA
$84.6M
| $929K | 0.12% |
462,163
| – | – |
2021 Q3
5 quarters
|
|
|
18
Grove Collaborative
GROV
$46M
| $755K | 0.1% |
377,345
+28,532
| +8% | +$146K |
2022 Q2
2 quarters
|
|
|
19
JFrog
FROG
$13.6B
| $512K | 0.07% |
+23,987
| New | +$545K |
2022 Q4
0 quarters
|
|
20
TaoWeave Inc
TWAV
$4.73M
| $443K | 0.06% |
6,154
| – | – |
2021 Q3
5 quarters
|
|
21
Amplitude
AMPL
$2.19B
| $60.1K | 0.01% |
+4,972
| New | +$70.4K |
2022 Q4
0 quarters
|
|
|
22
Sweetgreen
SG
$1.54B
| $54.7K | 0.01% |
+6,379
| New | +$93K |
2022 Q4
0 quarters
|
|
23
DELISTED
Confluent
CFLT
| $54.4K | 0.01% |
+2,447
| New | +$56.7K |
2022 Q4
0 quarters
|
|
|
AMRS
24
DELISTED
Amyris Inc.
AMRS
| $4.31K | ﹤0.01% |
+2,816
| New | +$6.29K |
2022 Q4
0 quarters
|
|
25
DELISTED
ACV Auctions
ACVA
| – | – |
-8,816
| Closed | -$63K | – |
|
Similar funds
StepStone Group's Q4 2022 Portfolio in Review
As of Q4 2022, StepStone Group held 35 positions worth $760M, up 8.1% from $703M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
StepStone Group's Q4 2022 filing shows 5 new, 3 increased, 2 reduced and 11 closed positions. Its largest new stake was JFrog: 23,987 shares worth $512K. The largest sale was UserTesting, Inc., an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- StepStone Group's largest Q4 2022 buy was JFrog: 23,987 shares worth $512K.
- StepStone Group added most to MoneyLion Inc. in Q4 2022, an estimated $800K increase.
- StepStone Group's biggest Q4 2022 reduction was UserTesting, Inc., cutting an estimated $14M.
- StepStone Group fully exited Forge Global Holdings in Q4 2022, selling an estimated $396K.
- StepStone Group's ten largest holdings make up 94% of its $760M portfolio in Q4 2022.
- StepStone Group opened 5 new positions and closed 11 in Q4 2022.
- StepStone Group's portfolio value rose 8.1% quarter-over-quarter to $760M.
Based on StepStone Group's 13F filing for Q4 2022, filed 10 Feb 2023.